Correlation Between Legacy Education and Raphael Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Legacy Education and Raphael Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Legacy Education and Raphael Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Legacy Education and Raphael Pharmaceutical, you can compare the effects of market volatilities on Legacy Education and Raphael Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Legacy Education with a short position of Raphael Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Legacy Education and Raphael Pharmaceutical.

Diversification Opportunities for Legacy Education and Raphael Pharmaceutical

0.25
  Correlation Coefficient

Modest diversification

The 3 months correlation between Legacy and Raphael is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Legacy Education and Raphael Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Raphael Pharmaceutical and Legacy Education is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Legacy Education are associated (or correlated) with Raphael Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Raphael Pharmaceutical has no effect on the direction of Legacy Education i.e., Legacy Education and Raphael Pharmaceutical go up and down completely randomly.

Pair Corralation between Legacy Education and Raphael Pharmaceutical

Given the investment horizon of 90 days Legacy Education is expected to generate 0.48 times more return on investment than Raphael Pharmaceutical. However, Legacy Education is 2.09 times less risky than Raphael Pharmaceutical. It trades about 0.33 of its potential returns per unit of risk. Raphael Pharmaceutical is currently generating about -0.12 per unit of risk. If you would invest  402.00  in Legacy Education on September 2, 2024 and sell it today you would earn a total of  419.00  from holding Legacy Education or generate 104.23% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy72.31%
ValuesDaily Returns

Legacy Education  vs.  Raphael Pharmaceutical

 Performance 
       Timeline  
Legacy Education 

Risk-Adjusted Performance

25 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Legacy Education are ranked lower than 25 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Legacy Education showed solid returns over the last few months and may actually be approaching a breakup point.
Raphael Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Raphael Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Legacy Education and Raphael Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Legacy Education and Raphael Pharmaceutical

The main advantage of trading using opposite Legacy Education and Raphael Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Legacy Education position performs unexpectedly, Raphael Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Raphael Pharmaceutical will offset losses from the drop in Raphael Pharmaceutical's long position.
The idea behind Legacy Education and Raphael Pharmaceutical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account